Host Defense in Oral Candidiasis

口腔念珠菌病的宿主防御

基本信息

  • 批准号:
    7848268
  • 负责人:
  • 金额:
    $ 34.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-06-22 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Perturbations in host defenses can result in overgrowth of pathogens such as Candida albicans, resulting in a painful and debilitating condition, oropharyngeal candidiasis (OPC). Inadequate immune responses, through aging, chemotherapy or immune deficiency, are associated with increased risk of OPC. These disorders are reemerging due to the prevalence of AIDS, both in the underdeveloped world where HAART is not available, and in cases where drug resistance develops. The proinflammatory cytokine, interleukin-1 is critical in host defense against both disseminated and mucosal Candida infections yet the mechanisms that underlie the production of IL-1 or of IL-1-mediated protection in OPC are unknown. We have developed a mouse model of OPC that will be utilized to determine the innate immune mechanisms regulating IL-1 (3 production in vivo and will develop in vitro systems to define these mechanisms in molecular detail. Acute inflammatory responses are generated via germ-line encoded pattern-recognition receptors (PRRs) that recognize specific molecular structures on pathogens known as pathogen associated molecular patterns (PAMPs). Toll-like receptors (TLRs) constitute a class of membrane bound PRRs expressed on host cells, including human oral epithelial cells (HOECs). In addition to TLRs, a large family of cytoplasmic PRRs known as the NACHT-LRRs (NLRs) or inflammasome have been implicated in innate responses, particularly in the processing of the immature form of IL-1 (pro-IL-1). The central hypothesis to be tested is that interactions of fungal pathogens with TLRs (with or without the TLR2 co-receptor, dectin-1) or NLRs at the oral mucosa are critical for controlling Candida infections in the oral cavity and that induction of IL-1P is critical for protection. We propose the following specific aims: 1) To identify critical PRRs involved in the pathogenesis of localized and disseminated infection in OPC, 2) To define the potential role of the NLR family in the induction, processing and release of IL-1P in Candida infections. The ontogeny of expression and function of these innate PRRs will be defined. The long term goals of this project are to determine the innate immune receptors and pathways involved in host defense against the oral pathogen Candida albicans and develop novel approaches to host immunomodulation and anti-fungal therapeutic modalities.
描述(由申请人提供):宿主防御系统的紊乱可导致病原体(如白色念珠菌)过度生长,导致疼痛和虚弱的状况,即口咽念珠菌病(OPC)。由于衰老、化疗或免疫缺陷导致的免疫应答不足与OPC风险增加有关。由于艾滋病的流行,这些疾病正在重新出现,无论是在没有高效抗逆转录病毒疗法的不发达国家,还是在耐药性发展的情况下。促炎细胞因子白细胞介素-1在宿主防御播散性和粘膜念珠菌感染中至关重要,但OPC中IL-1产生或IL-1介导的保护的机制尚不清楚。我们已经开发了一种OPC小鼠模型,该模型将用于确定体内调节IL-1 β产生的先天免疫机制,并将开发体外系统以详细定义这些机制。急性炎症反应是通过生殖系编码的模式识别受体(PRR)产生的,PRR识别病原体上的特定分子结构,称为病原体相关分子模式(PAMP)。Toll样受体(TLR)构成一类在宿主细胞(包括人口腔上皮细胞(HOEC))上表达的膜结合PRR。除了TLR之外,称为NACHT-LRR(NLR)或炎性体的细胞质PRR的大家族已经涉及先天性应答,特别是在IL-1的未成熟形式(pro-IL-1)的加工中。待检验的中心假设是,真菌病原体与TLR(有或没有TLR 2共受体,dectin-1)或NLR在口腔粘膜的相互作用是控制口腔念珠菌感染的关键,IL-1 P的诱导是保护的关键。我们提出了以下具体目标:1)确定参与OPC局部和播散性感染发病机制的关键PRR,2)确定NLR家族在念珠菌感染中诱导、加工和释放IL-1 P的潜在作用。这些先天PRR的表达和功能的个体发育将被定义。该项目的长期目标是确定宿主防御口腔病原体白色念珠菌的先天免疫受体和途径,并开发宿主免疫调节和抗真菌治疗方式的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amy G Hise其他文献

Amy G Hise的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amy G Hise', 18)}}的其他基金

Host factors affecting susceptibility to Candida auris.
影响耳念珠菌易感性的宿主因素。
  • 批准号:
    10553153
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Host factors affecting susceptibility to Candida auris.
影响耳念珠菌易感性的宿主因素。
  • 批准号:
    10015521
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Host factors affecting susceptibility to Candida auris.
影响耳念珠菌易感性的宿主因素。
  • 批准号:
    10347167
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Mucosal innate immune defense to Rift Valley fever virus
针对裂谷热病毒的粘膜先天免疫防御
  • 批准号:
    8070132
  • 财政年份:
    2010
  • 资助金额:
    $ 34.46万
  • 项目类别:
Innate Immune Sensing of Rift Valley Fever Virus
裂谷热病毒的先天免疫感应
  • 批准号:
    8070135
  • 财政年份:
    2010
  • 资助金额:
    $ 34.46万
  • 项目类别:
Host Defense in Oral Candidiasis
口腔念珠菌病的宿主防御
  • 批准号:
    7840840
  • 财政年份:
    2009
  • 资助金额:
    $ 34.46万
  • 项目类别:
Mucosal innate immune defense to Rift Valley fever virus
针对裂谷热病毒的粘膜先天免疫防御
  • 批准号:
    7924122
  • 财政年份:
    2009
  • 资助金额:
    $ 34.46万
  • 项目类别:
Innate Immune Sensing of Rift Valley Fever Virus
裂谷热病毒的先天免疫感应
  • 批准号:
    7894973
  • 财政年份:
    2009
  • 资助金额:
    $ 34.46万
  • 项目类别:
Mucosal innate immune defense to Rift Valley fever virus
针对裂谷热病毒的粘膜先天免疫防御
  • 批准号:
    7712717
  • 财政年份:
    2009
  • 资助金额:
    $ 34.46万
  • 项目类别:
Innate Immune Sensing of Rift Valley Fever Virus
裂谷热病毒的先天免疫感应
  • 批准号:
    7513357
  • 财政年份:
    2009
  • 资助金额:
    $ 34.46万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 34.46万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 34.46万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 34.46万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 34.46万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 34.46万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 34.46万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 34.46万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 34.46万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 34.46万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 34.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了